![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of exposure to each antiretroviral treatment (ARV) on the risk of fracture in HIV-infected individuals
|
|
|
Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
D Costagliola1, V Potard1, 7, S Lang1,7, S Abgrall 1, 6, C Duvivier2, H Fisher3, V Joly 4, JM Lacombe1,7, MA Valentin1,5, M Mary-Krause1, S Rozenberg5
(1) Sorbonne Universites, INSERM, UPMC Paris Univ 06, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, (2) Institut Pasteur, Centre Medical-Centre d'Infectiologie Necker-Pasteur, Paris, (3) TRT5, Paris, (4) APHP, Hopital Bichat, Paris, (5) APHP, Hopital Pitie-Salpetriere, Paris, (6) APHP, Hopital Antoine Beclere, Clamart, (7) Inserm Transfert, Paris, France
![IAS1](../images/072717/072717-1/IAS1.gif)
![IAS2](../images/072717/072717-1/IAS2.gif)
![IAS3](../images/072717/072717-1/IAS3.gif)
![IAS4](../images/072717/072717-1/IAS4.gif)
![IAS5](../images/072717/072717-1/IAS5.gif)
![IAS6](../images/072717/072717-1/IAS6.gif)
![IAS7](../images/072717/072717-1/IAS7.gif)
![IAS8](../images/072717/072717-1/IAS8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|